145 related articles for article (PubMed ID: 3752975)
1. Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.
Hirschhorn L; Neu HC
Antimicrob Agents Chemother; 1986 Jul; 30(1):143-6. PubMed ID: 3752975
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
Hirschhorn L; Neu HC
Chemotherapy; 1987; 33(1):28-39. PubMed ID: 3549179
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.
Smith BR; LeFrock JL; Donato JB; Joseph WS; Weber SJ
Antimicrob Agents Chemother; 1986 Feb; 29(2):355-8. PubMed ID: 3717937
[TBL] [Abstract][Full Text] [Related]
5. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
Hardy DJ; Swanson RN; Hensey DM; Ramer NR; Bower RR; Hanson CW; Chu DT; Fernandes PB
Antimicrob Agents Chemother; 1987 Nov; 31(11):1768-74. PubMed ID: 3435123
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.
Eliopoulos GM; Moellering AE; Reiszner E; Moellering RC
Antimicrob Agents Chemother; 1985 Oct; 28(4):514-20. PubMed ID: 3935046
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of A-56619 and A-56620, two new quinolones.
Barry AL; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
[TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Fernandes PB; Chu DT; Bower RR; Jarvis KP; Ramer NR; Shipkowitz N
Antimicrob Agents Chemother; 1986 Feb; 29(2):201-8. PubMed ID: 3521473
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Chin NX; Figueredo VM; Novelli A; Neu HC
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial spectrum of Win 49375.
Jacobus NV; Tally FP; Barza M
Antimicrob Agents Chemother; 1984 Jul; 26(1):104-7. PubMed ID: 6476813
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests.
Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
Eur J Clin Microbiol; 1986 Feb; 5(1):18-22. PubMed ID: 2938944
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones.
Digranes A; Dibb WL
Chemotherapy; 1988; 34(4):298-307. PubMed ID: 3208547
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
Wise R; Andrews JM; Ashby JP; Matthews RS
Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
Pohlod DJ; Saravolatz LD
Antimicrob Agents Chemother; 1984 Mar; 25(3):377-9. PubMed ID: 6326666
[TBL] [Abstract][Full Text] [Related]
15. In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.
Thompson KD; O'Keefe JP; Tatarowicz WA
Antimicrob Agents Chemother; 1984 Aug; 26(2):275-6. PubMed ID: 6435518
[TBL] [Abstract][Full Text] [Related]
16. Bacterial resistance to fluoroquinolones.
Neu HC
Rev Infect Dis; 1988; 10 Suppl 1():S57-63. PubMed ID: 3279500
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Barry AL; Jones RN
Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Neu HC; Labthavikul P
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Chin NX; Novelli A; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):656-62. PubMed ID: 3164987
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Soussy CJ; Deforges L; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
